Dr. Kased is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
916 Sycamore Ave
Suite D100
Vista, CA 92081Phone+1 619-244-1711Fax+1 760-599-9549
Education & Training
- University of California (San Francisco)Residency, Radiation Oncology, 2009 - 2013
- University of California San Francisco School of MedicineClass of 2008
- University of California San Diego School of MedicineB.S., Biology, Summa cum laude, 1999 - 2002
Certifications & Licensure
- CA State Medical License 2010 - 2025
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2013
- Quarterly Research Fellowship UCSF, 2006
- Dean’s Prize Award for Outstanding Medical Student Research, Finalist UCSF, 2004, 2006
- Join now to see all
Publications & Presentations
PubMed
- 1045 citationsSummary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain MetastasesPaul W. Sperduto, Norbert Kased, David Roberge, Zhiyuan Xu, Ryan Shanley
Journal of Clinical Oncology. 2012-02-01 - 116 citationsThe effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer.Paul W. Sperduto, Norbert Kased, David Roberge, Samuel T. Chao, Ryan Shanley
Journal of Neuro-Oncology. 2013-03-06 - 258 citationsEffect of Tumor Subtype on Survival and the Graded Prognostic Assessment for Patients With Breast Cancer and Brain MetastasesPaul W. Sperduto, Norbert Kased, David Roberge, Zhiyuan Xu, Ryan Shanley
International Journal of Radiation Oncology, Biology, Physics. 2012-04-01
Journal Articles
- The Effect of Tumor Subtype on the Time from Primary Diagnosis to Development of Brain Metastases and Survival in Patients with Breast CancerSperduto PW, Kased N, Roberge D, Chao ST, Shanley R, Luo X, Sneed PK, Suh J, Weil RJ, Jensen AW, Brown PD, Shih HA, Kirkpatrick J, Gaspar LE, Fiveash JB, Chiang V, Kni..., J Neurooncol, 1/1/2013
- Reply to MC Chamberlain et alSperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X, Sneed PK, Chao ST, Weil RJ, Suh J, Bhatt A, Jensen AW, Brown PD, Shih H, Kirkpatrick J, Gaspar LE, Fiveash JB..., J Clin Oncol, 1/29/2012
- Summary report on the graded prognostic assessment (GPA): An accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastasesSperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X, Sneed PK, Chao ST, Weil RJ, Suh J, Bhatt A, Jensen AW, Brown PD, Shih H, Kirkpatrick J, Gaspar LE, Fiveash J..., J Clin Oncol, 1/1/2012
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Evidence of interaction between HER2 and estrogen/progesterone (ER/PR) receptor status in patients with breast cancer and brain metastasesSperduto PW, Shanley R, Luo X, Kased N, Sneed P, Roberge D, Chao S, Weil R, Suh J, Bhatt A, Jensen A, Brown PD, Shih H, Kirkpatrick J, Gaspar LE, Fiveash J, Chiang V, ..., 17th Annual Meeting of the Society for NeuroOncology, Washington, DC, 1/1/2012
- Lymphatic drainage mapping of the prostate using filtered 99mTc-sulfur nanocolloid and SPECT/CTSeo Y, Aparici CM, Lee CL, Chen CP, Hsu CC, Kased N, Schreck C, Hawkins R Shinohara K, Roach M III, Annual Meeting of the Society of Nuclear Medicine, San Antonio, TX, 1/1/2011
- The effect of tumor subtype on survival and the graded prognostic assessment (GPA) for patients with breast cancer and brain metastasesSperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X, Sneed PK, Chao ST, Weil RJ, Suh J, Bhatt A, Jensen AW, Brown PD, Shih H, Kirkpatrick J, Gaspar LE, Fiveash J..., American Society of Clinical Oncology Breast Cancer Symposium, San Francisco, CA, 1/1/2011
- Join now to see all
Lectures
- Are planning target volumes derived from 4DCT scans adequate when treating lung SBRT with static tracking methods?Indianapolis, IN - 1/1/2013
- The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in women with breast cancerBoston, MA - 1/1/2012
- A review of the reference standards used in studies assessing the diagnostic accuracy of MRI and CT for hepatocellular carcinomaChicago, IL - 1/1/2008
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: